При две краткосрочни (24- часови) плацебо- контролирани проучвания с участието на 554 болни от шизофрения, показващи ажитация и смущения в поведението, арипипразол разтвор за
In two short- term (24-hour) placebo-controlled trials involving 554 schizophrenic patients presenting with agitation and disturbed behaviours, aripiprazole solution for injection was associated with statistically significant greater improvements in agitation/ behavioural symptoms compared to placebo and was similar to haloperidol.